Resources
We are indebted to the International Doctors for Healthier Drug Policies for our Resources. We will be adding to them over time.
The road to UNGASS 2016: Process and policy asks from IDPC
This document outlines the five main “asks” that the International Drug Policy Consortium members will collectively call for between now and the United Nations General Assembly Special Session (UNGASS) to be held in New York in the summer of 2016.
An injection of reason: Critical analysis of bill C-2 in Canada
The Government of Canada devised Bill C-2 (An Act to amend the Controlled Drugs and Substances Act), a piece legislation that would make supervised consumption services harder to establish.
Yet another dimension of the ineffectiveness of supply-side interventions in illegal drug markets
The growing literature on the effectiveness of supply-side interventions in illegal drug markets shows that most measures taken to curb supply (crop eradication, drug seizures, arrests of drug traffickers and dealers, etc.) have very small effects on quantities transacted.
Médicos afirmam que saúde deve ser central nas políticas de drogas
IDHDP estarão presentes no Rio de Janeiro na conferência global 2016 (de 10 a 12 de Novembro). O propósito da sessão IDHDP na manhã do dia 11 será incidir sobre os problemas de drogas que estão afetando severamente a região latino-americana, e sugerir alternativas à base da saúde.
Drug policy, harm reduction and young people: USA
This case study offers an overview of some of the main drug policy issues facing young people in the USA, looking at the impacts of the drug policy and harm reduction on young people, drawing data and evidence from official national statistics and experiences of young people who use drugs themselves.
Drug-related deaths in Scotland in 2013
The Scottish statistics of drug-related deaths in 2013 and earlier years, broken down by age, sex, selected drugs reported, report that the death following opioid overdose have gone down by 41 because of naloxone programmes.
Advocacy for the human rights of People Who Use Drugs
This study examines how and to what extent advocacy for human rights of People who Use Drugs is currently used and how human rights advocacy can further improve the effectiveness of harm reduction strategies and services.
Ketamine for depression: New review highlights the need for an RCT
Mainly used in veterinary surgery, ketamine has been discovered to rapidly improve even the most severe cases of unipolar and bipolar depression. However, as yet there are still many questions left unanswered before ketamine can become a licensed treatment alternative. This study provides a systematic review of methodologically sound studies.
Drugs: International comparators
This International Comparators Study on drugs was conducted by ministers and officials from the Home Office took established to examine national drug policies adopted by a range of countries to tackle drug misuse and dependency.
A therapeutic workplace for the long-term treatment of drug addiction and unemployment: Eight-year outcomes of a social business intervention.
This study evaluated the long-term effects of a therapeutic workplace social business on drug abstinence and employment. This paper reports 4- to 8-year outcomes. During year 4 when a business was open, therapeutic workplace participants provided significantly more cocaine- and opiate-negative urine samples than controls; reported more days employed, higher employment income, and less money spent on drugs.
Persisting pain in children package: WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
These new WHO guidelines outline basic principles, clinical recommendations and health system recommendations. This brochure highlights selected issues which are essential for, in particular, policy-makers, medicines regulatory authorities, hospital managers and health insurance managers.
UNAIDS gap report: Beginning of the end of the AIDS epidemic
Although the number of people who are newly infected with HIV is declining, people who inject drugs are almost universally criminalised and have less access to HIV treatment.
Opioid-related deaths in Australia
From 2007 to 2009, the number of opioid drug deaths identified on the National Coronial Information System (NCIS) increased by 25.0%. Heroin was the opioid drug most frequently involved in death (particularly in cases of sole drug involvement), with 84.4% of all heroin-related deaths involving males. 87.6% of all heroin related deaths were unintentional in nature.
Maintenance therapy for injection-drug users associated with lower incidence of hepatitis C
In a group of young users of injection drugs, recent maintenance opioid agonist therapy with methadone or buprenorphine for opioid use disorders, such as heroin addiction, was associated with a lower incidence of hepatitis C virus infection and may be an effective strategy to reduce injection-drug use and the resulting spread of HCV, according to a study.
DrugLink: October-September 2014
This number of DrugLink covers a lot of health-related topics, such as the arguments in the medical community around prescribing injectable or oral drugs and over private prescribing, drug rehabilitation, HIV and injecting drug use, Hepatitis C, etc.
Evidence from the frontline: How policy changes are affecting people experiencing multiple needs
In the UK, 88% of services reported welfare changes had a negative effect on their clients’ overall well-being, and 86% on their mental health. 41% of mental health services said moving the substance misuse budget to public health has had a negative impact.
Key findings from the 2014 IDRS: A survey of people who inject drugs
The Illicit Drug Reporting System (IDRS) monitors emerging trends in the use, price, purity and availability of heroin, methamphetamine, cocaine, cannabis and other drugs.
National HIV league report in Myanmar
This report presents the key findings and recommendation of the review of Myanmar's legal framework and its impact on access to health and HIV prevention and treatment services for people living with HIV and key populations. This review was conducted through a partnership of UNAIDS, UNDP and Pyoe pin in the period August - December 2013, in consultation with the National AIDS programme.
Current status of drug use and HIV/AIDS prevention in drug users in China
In China, the number of amphetamine-type stimulant users has increased sharply. The strengthening of antiretroviral therapy (ART) treatment for HIV-infected drug users is crucial for HIV/AIDS prevention and control.
Prisons and health
This report outlines important suggestions by international experts to improve the health of people in prison and to reduce the risks posed by imprisonment to both health and society. In particular, it aims to facilitate better prison health practices in the fields of human rights and medical ethics, communicable diseases; noncommunicable diseases; oral health; risk factors; vulnerable groups; and prison health management.
Health interventions for prisioners
The WHO compiles in this document several studies that have demonstrated that HIV prevention programmes, including education, condom distribution, OST, and needle and syringe programmes, can be successfully implemented in prisons and other closed settings.
The relationship between US heroin market dynamics and heroin‐related overdose, 1992–2008
This paper hypothesizes that components of the US illicit drug market, specifically heroin source/type, price and purity, will have independent effects on the number of heroin‐related overdose hospital admissions.
Alcohol and other drug treatment and diversion from the Australian criminal justice system: 2012-13
In Australia, there were 24,069 clients who had been diverted into alcohol and other drug treatment, comprising 24% of all clients. Diversion clients were younger and more likely to be male than non-diversion clients, and less likely to be Indigenous. Diversion treatment episodes were about twice as likely to involve cannabis as the principal drug of concern compared with episodes for non-diversion clients.
The road to UNGASS 2016: Process and policy asks from IDPC
This document outlines the five main “asks” that the International Drug Policy Consortium members will collectively call for between now and the United Nations General Assembly Special Session (UNGASS) to be held in New York in the summer of 2016.
Deaths Related to Drug Poisoning in England and Wales, 2013
Male drug poisoning increase by 19% compared with England and Wales in 2013. Female drug poisoning has been increasing since 2009. Heroin/morphine remain the substances most commonly involved in drug poisoning deaths.
Not just in transit drugs: The state and society in West Africa
A destructive new threat is jeopardizing this progress in West Africa: with local collusion, international drug cartels are undermining our countries and communities, and devastating lives.
A defence of drug prohibition (Don Weatherburn)
This paper acknowledges that social and financial costs of the prohibition against illegal drugs but argues that prohibition also prevents a great deal of harm
A critique of drug prohibition (Alex Wodak)
Drug prohibition has proved to be an expensive way of making a bad problem worse: its major success has been as a political strategy.
A response to a critique (Don Weatherburn)
The principal weakness with Alex Wodak’s response to my original article is that the points he makes, whether accepted or not, have little bearing on the arguments I put.
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
The rate of death from overdoses of prescription opioids in the United States more than quadrupled between 1999 and 2010 far exceeding the combined death toll from cocaine and heroin overdoses.